Critical Reviews in Oncogenesis
SJR0.565
US
USJournal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | — | — | 0.565 | Q2 | 65.5% | |
| 2024 | — | — | 0.553 | Q2 | 65.7% | |
| 2023 | — | — | 0.319 | Q3 | 50.7% | |
| 2022 | — | — | 0.395 | Q3 | 58.9% | |
| 2021 | — | — | 0.397 | Q3 | 60.0% | |
| 2020 | — | — | 0.478 | Q3 | 64.9% | |
| 2019 | — | — | 0.580 | Q3 | 71.7% | |
| 2018 | — | — | 0.631 | Q3 | 72.1% | |
Impact history
Annual SJR and Impact Factor trend.
SJR
Journal record
eISSN
0893-9675
ISSN
2162-6448
country
UScoverage
1989-2000, 2006-2009, 2011-2025